Evaluation of the Safety and Efficacy of TLD in Patients with COPD
NCT03639051
·
clinicaltrials.gov ↗
NA
Phase
ACTIVE_NOT_RECRUITING
Status
464
Enrollment
INDUSTRY
Sponsor class
Conditions
COPD
Interventions
DEVICE:
Targeted Lung Denervation (TLD)
OTHER:
Optimal Medical Care
Sponsor
Nuvaira, Inc.